GEN Magazine – Smooth Collaboration Between CDMOs and Tech Providers Boosts AAV Manufacturing Efficiency.
GEN, one of the biggest magazines in the field of genetic engineering and biotechnology, discussed with four experts how the relationship between a CDMO and a technology provider can accelerate the transition from academia to the industry while nimbly navigating technology challenges. Magnus Gustafsson and Artur Padzik from Biovian joined the discussion with representatives from Cytiva and Pall.
Read the online article, or download a copy.
When you’re starting a new gene therapy company, you must decide what to do in-house and what to outsource. New companies need development and manufacturing that’s flexible and agile, but internal fixed costs are high. CDMOs provide this flexibility and agility.”
Magnus GustafssonBiovian
